GNRH1 and Dravet syndrome: Another prevalent DS-associated phenotype suggests that puberty may mark a critical period in the disease progression, as many people with DS experience a progressive loss of smell and a worsening of cognitive symptoms around this time.3 Focusing on this subset of DS individuals, Manfredi-Lozano and colleagues identified GnRH as a potential therapeutic target by connecting four pieces of evidence.